These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11729829)

  • 1. Capability of adriamycin and busulfan to induce adaptive response in vitro.
    Anuszewska EL; Koziorowska JH
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):51-4. PubMed ID: 11729829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on adaptation to adriamycin in cells pretreated with hydrogen peroxide.
    Anuszewska EL; Gruber BM; Koziorowska JH
    Biochem Pharmacol; 1997 Sep; 54(5):597-603. PubMed ID: 9337076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanisms of an H2O2 adaptive dose on DNA damage in human neoplastic cells treated with adriamycin.
    Gruber BM; Anuszewska EL
    Acta Pol Pharm; 2000; 57(3):193-8. PubMed ID: 11143708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of the antitumor transplantation resistance in rats by the antileukemia drug busulfan (author's transl)].
    Mizushima Y
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):537-42. PubMed ID: 7274985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD; Sun JZ; Bi DS; Ma R
    Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Terminalia arjuna extract on adriamycin-induced DNA damage.
    Reddy TK; Seshadri P; Reddy KK; Jagetia GC; Reddy CD
    Phytother Res; 2008 Sep; 22(9):1188-94. PubMed ID: 18729254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B
    Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive response towards adriamycin in vitro: circumvention with verapamil.
    Anuszewska EL; Koziorowska JH
    Mutat Res; 1999 Dec; 431(1):25-30. PubMed ID: 10656483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional effects of adriamycin on cardiac cells in vitro.
    Lampidis TJ; Henderson IC; Israel M; Canellos GP
    Cancer Res; 1980 Nov; 40(11):3901-9. PubMed ID: 7471041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The adaptive response of B cells to the action of cytotoxic preparations in culture. III. The possible mechanism of the action of adriamycin on immunoglobin synthesis by the cells of murine myeloma].
    Meliksetian MB; Davtian TK; Ivanova IV; Aleksanian IuT; Ignatova TN
    Tsitologiia; 1993; 35(6-7):98-104. PubMed ID: 8266570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen peroxide overload increases adriamycin-induced apoptosis of SaOS(2)FM, a manganese superoxide dismutase-overexpressing human osteosarcoma cell line.
    Wang Y; Kuroda M; Gao XS; Asaumi J; Shibuya K; Kawasaki S; Akaki S; St Clair D; Hiraki Y; Kanazawa S
    Int J Oncol; 2005 May; 26(5):1291-300. PubMed ID: 15809720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.
    De Graff WG; Myers LS; Mitchell JB; Hahn SM
    Int J Oncol; 2003 Jul; 23(1):159-63. PubMed ID: 12792789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
    Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro responses of mammalian cells to drug-induced potentially lethal and sublethal damage.
    Barranco SC
    Cancer Treat Rep; 1976 Dec; 60(12):1799-810. PubMed ID: 1026336
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
    Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
    Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of vitamins C and E on cytotoxic activity of adriamycin in chosen cell cultures.
    Woźniak G; Anuszewska EL
    Acta Pol Pharm; 2002; 59(1):31-5. PubMed ID: 12026110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.
    Barranco SC; Novak JK
    Cancer Res; 1974 Jul; 34(7):1616-8. PubMed ID: 4858112
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of models in "target" theory to evaluate the survival curves of human ovarian carcinoma cell line exposure to adriamycin combined with ultrasound.
    Yu T; Xiong Z; Chen S; Tu G
    Ultrason Sonochem; 2005 Apr; 12(5):345-8. PubMed ID: 15590307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of a K562 multidrug-resistant cell line and study on proteins with altered expression].
    Wang Y; Cao J; Zeng S
    Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):342-6. PubMed ID: 14724945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].
    Chen J; Yuan YW; Zhang JR; Zhou DY
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):124-6. PubMed ID: 12390804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.